Furthermore, the single-cell DHSs predict enhancers that regulate cellspecific gene expression programs and the cell-to-cell variations of DHS are predictive of gene expression. Finally, we apply scDNase-seq to pools of tumour cells and pools of normal cells, dissected from formalin-fixed paraffin-embedded tissue slides from patients with thyroid cancer, and detect thousands of tumour-specific DHSs. Many of these DHSs are associated with promoters and enhancers critically involved in cancer development. Analysis of the DHS sequences uncovers one mutation (chr18: 52417839G>C) in the tumour cells of a patient with follicular thyroid carcinoma, which affects the binding of the tumour suppressor protein p53 and correlates with decreased expression of its target gene TXNL1. In conclusion, scDNase-seq can reliably detect DHSs in single cells, greatly extending the range of applications of DHS analysis both for basic and for translational research, and may provide critical information for personalized medicine.
generated DHS profiles of 10,000, 1,000, 100 and even single cells comparable to that of mouse ENCODE data obtained from 10 million to 20 million cells ( Fig. 1b) . On average, about 317,000 unique scDNase-seq reads and 38,000 DHSs were detected per single cell. Although the numbers of mapped reads and DHSs decrease as the cell numbers decrease, the enrichments of reads in DHSs in different single cells were very similar (23-26% of reads in DHS regions), despite minor differences ( Supplementary Tables 1-3 ). Scatter plot analysis indicated that the DHSs from 10,000, 1,000 and 100 cells are as reproducible as the ENCODE data (Fig. 1c, d and Extended Data Fig. 1a-c) . The pooled DHSs of five single NIH3T3 cells were significantly correlated with those of 1,000 cells ( Fig. 1e ). We also observed high correlation of DHSs between single cells ( Fig. 1f and Extended Data Fig. 1d-l) . Venn diagrams showed that at least 90% of DHSs in single cells could be detected in the 1,000-cells data ( Fig. 1g and Extended Data Fig. 2a-d ). Large fractions (41-82%) of DHSs were shared between two single cells ( Fig. 1h and Extended Data Fig. 2e-m) . Although only 35-59% of the DHS in the 1,000-cells data were detected in each single cell ( Fig. 1g and Extended Data Fig. 2a-d) , detectability increased to 72% when the five single cells were pooled ( Fig. 1i ), suggesting single-cell-specific DHSs contribute to the total number of DHSs detected in a population of cells.
The false discovery rates (FDRs) of single-cell libraries were 11-13% (Supplementary Table 2 ) when one scDNase-seq tag was detected within a DHS region, suggesting that even detection of one tag is likely to represent a true DHS. Indeed, transcription start sites (TSSs) with one tag exhibited significantly higher expression levels than those without any tag ( Fig. 2a and Extended Data Fig. 3a-d ). The tag number at TSSs positively correlated with expression levels when the number was low (zero to three tags), but expression levels did not significantly change when the number was high (more than three tags) ( Fig. 2a and Extended Data Fig. 3a-d) , indicating that the gene expression was no longer limited by accessibility once the promoter had become accessible. As expected, the tag density at TSSs in each single cell correlated with gene expression levels measured in a population of cells ( Fig. 2b and Extended Data Fig. 3e -h), and almost all promoters of highly expressed genes were accessible in each single cell ( Fig. 2c and Extended Data Fig. 3i -l). Consistent with these observations, the tag densities at housekeeping genes were higher and variations lower than those at tissue-specific genes (Fig. 2d ). The number of cells where a promoter exhibited DHS correlated with its gene expression: the genes with DHSs across all five single cells had the highest expression level ( Fig. 2e ). Further analysis showed that the genes with the lowest cell-to-cell variation at promoters were significantly enriched in basic cell functions such as transcription, cell cycle and RNA processing (Supplementary Table 4 ). The genes with the highest cell-to-cell variation were significantly enriched in metal ion binding (Supplementary Table 5 ).
Next we examined the fraction of overlapping open promoters where DHS was detected in either 1,000 cells or one single cell in different expression groups. The analysis revealed that although only 58-61% of Letter reSeArCH
the open promoters overlapped in the silent gene group, 98-99.9% of the open promoters in intermediately and highly expressed gene groups detected in a single cell overlapped with those detected in 1,000 cells ( Fig. 2f and Extended Data Fig. 4 ), indicating that the DHSs of active genes can be consistently detected in single cells.
Compared with promoter/proximal DHSs, distal DHSs showed lower tag density, higher cell-to-cell variation and noise (Extended Data Fig. 5a-d ). Nevertheless, distal DHSs in single cells were clearly enriched in active histone modifications (H3K4me1, H3K4me3, H3K9ac, H3K27ac and H2A.Z) but not repressive ones (H3K36me3, H3K9me2 and H3K27me3) ( Fig. 2g ), which is consistent with the scenario at the population level [6] [7] [8] [9] [10] [11] and validated our single-cell assay. Interestingly, DHS detectability in single cells correlated with the degree of enrichment of the active histone modification ( Fig. 2h and Extended Data Fig. 5e -h), and correlated with the number of active marks at the DHSs ( Fig. 2i and Extended Data Fig. 5i -l). The vast majority of DHSs were detected across all five single cells when five active histone modification marks were present, whereas DHSs exhibited in variable number of cells when only one or two active marks were present ( Fig. 2j ). These results indicate that DHS at enhancers are variable between different cells and provide strong evidence that multiple active histone modifications strongly correlated with chromatin accessibility across different single cells.
We compared the DHSs detectability in single cells with the tag density of DHSs from 1,000 cells or 20 million cells. The results indicated the detectability of DHSs in single cells positively correlated with the tag density from the library by a large number of cells ( Fig. 2k and Extended Data Fig. 5m ). We hypothesized that strong DHSs would be present in all the cells and weak DHSs in only a fraction. If this were the case, more strong DHSs and fewer weak DHSs should be detected within one single cell. Indeed, 80-90% of the strong DHSs were detected whereas only 20-30% of weak DHSs were detected in single cells ( Fig. 2k and Extended Data Fig. 5m ). Another prediction from this hypothesis was that relatively fewer strong DHSs and more weak DHSs would be additionally detected as we added up single cells. Pooling the five single cells indeed showed the fraction of detected weak DHSs was doubled, whereas the fraction of detected strong DHSs only increased by a small percentage ( Fig. 2k and Extended Data Fig. 5m ).
The variation of DHSs among single cells within a 'homogenous' population is reminiscent of the well-known phenomenon of variation of gene expression among single cells 12 . To study their relationship, we constructed 14 single embryonic stem-cell (ESC) scDNase-seq libraries ( Supplementary Tables 6-8 ). Comparison with single-cell RNA sequencing (RNA-seq) data 13 revealed that tag density and variation at TSS of single-cell scDNase-seq indeed correlated with that of single-cell gene expression (Extended Data Fig. 6a, b) . Furthermore, the genes with DHSs in fewer single cells showed high variation of expression and were expressed in fewer single cells ( Fig. 3a, b ). These results further indicate that the cell-to-cell variations of single-cell DHSs are predictive of gene expression. Consistent with this notion, we found a significantly higher correlation between the technical repeats compared with that of two non-technical repeat libraries (Extended Data Fig. 6c, d ). The Gene Ontology (GO) terms enriched among genes with the lowest and the highest cell-to-cell variation in the 14 ESCs were consistent with that in single 3T3 cells ( Supplementary Tables 9 and 10 ).
We next identified 1,735 NIH3T3-specific DHSs and 2,180 ESC-specific DHSs using the 5 NIH3T3 and 14 ESC single-cell scDNase-seq libraries. Heat map showed these cell-specific DHSs displayed expected cell specificity in all of the libraries (Fig. 3c ). The cell-specific DHSs were highly correlated with cell-specific gene expression (Extended Data Fig. 6e , f) and enriched in distinct biological functions (Extended Data Fig. 6g , h). Super-enhancers play a key role in regulating expression of critical cell-specific genes [14] [15] [16] . We identified 275 NIH3T3-specific and 231 ESC-specific superenhancers and compared their single-cell scDNase-seq tag densities. The subpeaks of 3T3-specific super-enhancers were associated with a substantially higher tag density in single 3T3 cells than that in ESCs, and vice versa ( Fig. 3d, e ), indicating that single-cell DHSs can help predict super-enhancers.
Chromatin defects underlie various diseases including cancers 17 . Profiling genome-wide chromatin accessibility in cells from patients, which are often limiting in numbers, would be clinically invaluable. We applied scDNase-seq to cells dissected from a follicular thyroid carcinoma (FTC) sample on formalin-fixed paraffin-embedded (FFPE) slides ( Fig. 4a ). DNase I digestion resulted in typical periodic cleavage patterns of nucleosome arrays and read enrichment around TSSs ( Fig. 4b and Extended Data Fig. 7a-c) . Likewise, the genome browser displays showed peaks ( Fig. 4c ), suggesting the cells recovered from the FFPE slides retained key chromatin features.
HMGA2 is upregulated in FTC 18, 19 and its promoter indeed exhibited higher accessibility in the tumour than that in adjacent normal cells ( Fig. 4d ). Overall, 1,342 tumour-specific and 2,812 normal-specific DHSs were identified (Extended Data Fig. 8a, b ). The genes associated with the tumour-specific DHSs were significantly enriched in the GO biological process terms such as regulation of GTPase activity and response to hypoxia, and pathways such as E-cadherin signalling, RhoA signalling, p53 pathway, RAC1 signalling and MYC transformation (Extended Data Fig. 8 ). Among these were several known genes such as TIAM1 and PIP4K2A (Extended Data Fig. 9a, b ), involved in tumours 20, 21 . Interestingly, genes that are characteristic of PAX8-PPARG fusion 22 in FTC were enriched in tumour-specific DHSs (Extended Data Fig. 8f and Supplementary Table 11 ), even though PPARG gene rearrangement was not detected by fluorescence in situ hybridization of FTC 440 (data not shown). This suggests that pathways associated with the transcriptional regulation by PAX8-PPARG, but not necessarily the PAX8-PPARG rearrangement itself, are important in mediating follicular thyroid tumorigenesis. We similarly analysed samples from two more FTC (797 and 957) and one papillary thyroid carcinoma (PTC from patient number 131) samples ( Supplementary Table 12 ). Comparison of the tumour-specific DHSs identified in the three FTC samples revealed very few shared DHSs among all three FTC samples (Extended Data Fig. 10a ). The HMGA2 promoter exhibited a strong DHS in the tumour cells but not in their neighbouring normal cells in FTC from patient number 440, whereas in the other two FTC cases (957 and 797) the promoter showed strong DHSs both in tumour and in normal cells (Extended Data Fig. 10b ). Instead, an intronic enhancer showed differential DHSs between the tumour and normal cells (Extended Data Fig. 10b ). These results suggest that the mis-regulation of HMGA2 in the tumour cells may be attributed to different regulatory elements in different patients. Analysis of PTC 131 also identified numerous tumour-cell-and normalcell-specific DHSs, which are enriched in disease ontologies (Extended Data Fig. 10c ). Overall, our results indicate that the vast majority of DHSs are patient-specific, implying that these tumours may arise or progress via different mechanisms in different patients.
To gain further mechanistic insight, we searched for genetic lesions within DHSs in FTC 440 by comparing the DHS sequence between tumour and normal cells. A total of 31 potential single nucleotide variations (SNVs) were identified in the DHS regions, which included both loss of heterozygosity of known SNPs and de novo mutations ( Supplementary Table 13 ). We confirmed the de novo mutation (chr18:52417839G> C) at a DHS downstream of the thioredoxin-like 1 gene (TXNL1) (Fig. 4e ). TXNL1 encodes a regulatory subunit of the human 26S proteasome 23 . Downregulation of TXNL1 is associated with poor prognostic outcomes, aneuploidy in colorectal carcinoma 24 and is implicated in cisplatin-induced apoptosis 25 . Interestingly, the G to C change appears to negatively impact the binding motif of p53 ( Fig. 4f ) and correlates with significantly decreased expression of TXNL1 in the tumour cells (Fig. 4g) ; p53 binds to this DHS in a human thyroid cell line (Fig. 4h) . The G to C mutation at this site compromises p53 binding ( Fig. 4i ) and impairs its ability to activate a reporter promoter ( Fig. 4j ), suggesting that the G to C change may underlie the decreased TXNL1 expression in the tumour cells (Fig. 4g ). This SNP was not detected in the other three patients (797, 957 and 131). Therefore, our strategy for searching SNVs in relevant DHS regions seems to be a cost-effective alternative to whole-genome sequencing for detecting functionally important mutations in regulatory regions.
Tn5-transposase-mediated detection of chromatin accessibility (scATAC-seq) 26, 27 in a large number of single cells has been reported recently. However, the reads per cell generated by scATAC-seq may be too sparse to examine the cell-to-cell variation at individual regulatory regions 26, 27 . In comparison, our scDNase-seq detects a much larger number of DHSs per cell, which provides information on cell-to-cell variations of individual DHSs. scDNase-seq is expected to find its use in multiple settings, such as the analysis of rare cell populations during lineage development and the study of clinical samples with extremely small numbers of cells such as circulating tumour cells, laser-captured cells, core biopsy or fine-needle aspiration samples. Being able to evaluate the chromatin states associated with specific diseases or developmental programs might provide valuable information for developing new diagnostic and therapeutic strategies for these malignancies.
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No statistical methods were used to predetermine sample size. The experiments were not randomized. The investigators were not blinded to allocation during experiments and outcome assessment. Cell culture and sorting. NIH/3T3 tet-on 3G cells (Clontech, 631197) were cultured in DMEM (Invitrogen, 10566-016) supplemented with 10% FBS (Sigma, F4135-500ML) and 100 U ml −1 penicillin-streptomycin (Invitrogen, 15140-122). Mouse ESCs were cultured as described 28 . Single-cell suspension after trypsinization was used for 4′ ,6-diamidino-2-phenylindole (DAPI) staining immediately before sorting by flow cytometry. Single live cells were sorted and deposited directly into each tube of a PCR strip-tube, which contained 30 μ l cell lysis buffer (10 mM Tris-HCl, pH 7.5, 10 mM NaCl, 3 mM MgCl 2 , 0.1% Triton X-100). DNase I digestion and scDNase-seq library preparation. To prevent loss of the extremely small amount of DNase I hypersensitive DNA (<0.1 pg) released by DNase I digestion of single cells, we added a large amount of circular plasmid DNA (30 ng; about 3 × 10 5 times the amount of the DHS DNA in a single cell) as carrier DNA in the subsequent steps of library preparation. The circular DNA was not compatible with the adaptor ligation and thus could minimize the nonspecific amplification by the subsequent PCR. The PCR conditions were optimized to amplify the small fragments (<200 base pairs (bp)) derived from DNase I hypersensitive sites without previous fractionation of these fragments.
For DNase I digestion, 0.2 to 1 unit of DNase I (Roche, 04716728001) was added to the cells and incubated at 37 °C for 5 min. The reaction was stopped by adding 80 μ l of stop buffer (10 mM Tris-HCl, pH 7.5, 10 mM NaCl, 0.15% SDS, 10 mM EDTA) containing 1 μ l of 20 mg ml −1 proteinase K and 5 μ l of 6 ng μ l −1 circular carrier DNA. The mixture was incubated at 55 °C for 1 h and DNA purified by phenol-chloroform extraction, followed by precipitation with ethanol in the presence of 20 μ g glycogen. The library was prepared using Illumina kits as described 29 . The libraries were amplified using a two-step method to preferentially amplify the small DNA fragments derived from the DNA hypersensitive sites and to reduce non-specific amplification of the carrier DNA. The first amplification was done with index primers with the PCR condition 98 °C for 10 s, 67 °C for 30 s, 72 °C for 30 s for six cycles. After isolation of the desired fragments (160-300 bp) using 2% E-gel (Invitrogen), the second amplification was done with the P5 and P7 primers with the condition 98 °C for 10 s, 68 °C for 30 s, 72 °C for 30 s for 22 cycles. The fragments between 160 and 300 bp were isolated on E-gel and sequenced on Illumina HiSeq 2500. Recovery of cells from FFPE tissue slides. The anonymized tumour samples from Ambry Genetics, approved by institutional review board and with informed consent, were used in this study. Three cases of thyroid cancer were diagnosed as FTC and one case was diagnosed as papillary thyroid carcinoma. Cells were manually scraped off from the highlighted area of a paraffin slide using a razor blade and resuspended in 150 μ l of de-paraffinization solution (Qiagen, 1064343) and incubated at 56 °C for 3 min. After cooling to room temperature (about 25 °C), 150 μ l of lysis buffer (10 mM Tris-HCl, pH 7.5, 10 mM NaCl, 3 mM MgCl 2 , 0.1% Triton X-100) was added and incubated at 37 °C for 2 h. The cells in the lower layer were transferred to a new tube and digested by DNase I as described above. The formaldehyde cross-linking was reversed by incubating DNA at 65 °C overnight, which was followed by DNA purification and library preparation.
Extraction of total RNAs from cells recovered from FFPE slides, RT-PCR,
RNA-seq. Cells recovered from FFPE slides were resuspended in 150 μ l of deparaffinization solution (Qiagen, 1064343) and incubated at 56 °C for 3 min. Total RNA was extracted using an RNA extraction kit from (Qiagen, 73504), following the manufacturer's instructions. After reverse transcription using an oligonucleotide dT primer, the mRNA expression levels of selected genes were analysed using the following gene-specific primers and probes from Applied Biosystems: HMGA2-Hs00171569_ml, TIAM1-Hs01021959_ml, TXNL1-Hs00355488_ml, PIP4K2A-Hs00178197_ml and GADPH-Hs99999905_ml.
The RNA-seq libraries were generated according to established protocols and sequenced on HiSeq 2500 platforms. Validation of SNVs by Sanger sequencing. The tumour and adjacent normal cells from FFPE slides were recovered and resuspended in 100 μ l of 1× TE + 0.1% SDS + 0.2 mg ml −1 proteinase K. Following incubation at 65 °C overnight, the genomic DNA was purified using phenol-chloroform extraction and ethanol precipitation. The genomic region containing the potential sequence variation was amplified by PCR using specific primers. The PCR products were then sequenced by Sanger sequencing. Forward primer, AAGCTAAATGAGCAAAATATTCCT; reverse primer, GGGAGGCTGAGGCAGTAGAATCG. ChIP, electrophoretic mobility shift assay and promoter reporter assays. Chromatin extracts were prepared from a human thyroid cell line (Nthy-ori 3-1 human Cell Line, from Sigma-Aldrich, 90011609). ChIP experiments were performed with p53 antibodies (Santa Cruz Biotechnology, sc-6243X) using established protocols 1 . The ChIP DNA was analysed using qPCR with the following primers: p53 positive forward primer, GTCATGCGATCTTGGCTCACT; reverse primer, CTTGGGAGGCTGAGGCAGTA; probe, CAACCTCCGCCTCCCGGGTTC. Control forward primer, CCCCATGCTGTTCTCGTGATA; reverse primer, GCAAAGGTGAATCAAGGCATCT; probe, TTTATAAGGTTCTCTTCC CCTTTCGCTGGG.
Electrophoretic mobility shift assay (EMSA) experiments were performed using nuclear extracts of HeLa cells transfected with a p53 expression vector (provided by J. Huang). Briefly, the double-stranded oligonucleotide probes (wild-type p53 site, CACTCTGTTGCCCGGGCTAGTGTGCAGT; tumour p53 site, CACTCTGTTGCCCGGGCTACTGTGCAGT; p21 promoter p53 site, CAGGAACAAGTCAAGACATGTTCAGC) were synthesized and labelled with biotin using Biotin 3zeEnd DNA Labelling Kit (Thermo Scientific, 89818). The EMSA assays were conducted by using LightShift Chemiluminescent EMSA Kit (Thermo Scientific, 20148) according to the manufacturer's instructions.
To test the activity of the p53 binding sites to activate a reporter promoter, we cloned the wild type p53 binding motif, the motif with the G to C mutation and the p53 motif from the p21 promoter into the XhoI and BglII upstream of the basal cytomegalovirus promoter driving a luciferase reporter gene (provided by J. Huang). The constructs were transfected into Nthy-ori 3-1 human cell line cells for 2 days and the luciferase activity of whole-cell extracts was measured using a Dual-Luciferase Reporter Assay kit (Promega, E1960). The oligonucleotide sequences used in the reporter constructs were as follows: wild type p53 site, TCGAGCTGTTGCCCGGGCTAGTGTGA; tumour p53 site, TCGAGCTGTTGCCCGGGCTACTGTGA; p21 promoter p53 site, TCGAGGAACAAGTCAAGACATGTTCA. Data analysis. Data, reads mapping and filtering: in this study, we constructed a total of 38 scDNase-seq libraries including 8 NIH3T3 libraries ( Supplementary  Table 1 ), 18 ESC libraries ( Supplementary Table 6 ) and 12 FFPE patient libraries ( Supplementary Table 12 ). Among these libraries, there are 5 NIH3T3 single-cell scDNase-seq libraries and 14 ESC single-cell scDNase-seq libraries. We also prepared eight RNA-seq libraries using cells recovered from the FFPE tissue section slides of FTC 440 ( Supplementary Table 12 ). In addition to the scDNase-seq and RNA-seq libraries prepared in this study, we integrated the histone modification ChIP-seq data of NIH3T3 from our previous study 30 . We also downloaded the DNase-seq data of NIH3T3 cells and ESCs from mouse ENCODE project 31 . Reads of DNase-seq/scDNase-seq/ChIP-seq were mapped to the mouse genome (mm9) or human genome (hg18) using Bowtie2 (ref. 32 ). Iterative alignment, in which the unmapped reads were trimmed 5 bp and were re-aligned until reads were less than 26 bp, were conducted for small cell number scDNase-seq libraries and single-cell scDNase-seq libraries. The reads with mapping quality (MAPQ) ≤ 10 or redundant reads that mapped to the same location with the same orientation were removed from further analysis in each library. The mappability of 1,000-cells scDNase-seq libraries to the mouse or human genome was about 40% whereas that of the single-cell scDNase-seq libraries was about 2% owing to non-specific amplification of carrier DNA. The tag density at each bin of 200 bp was calculated by normalizing the number of reads in the bin to the total number of reads in the library and the bedgraphs were uploaded to the UCSC Genome Browser.
Peak calling for DNase-seq/scDNase-seq and correlation between different libraries: the DHSs in mouse ENCODE DNase-seq data and small cell number scDNase-seq data were identified using model-based analysis of ChIP-seq (MACS) 33 by setting a P value to 1 × 10 −5 . The peaks identified in the ENCODE data were extended ± 1 kb from the summit of the peak if the peak size was < 2 kb and overlapping peaks were merged. Then the number of reads in each DHS for all DNase-seq and scDNase-seq libraries was counted. The tag density at each DHS was calculated by normalizing the number of reads in the DHS to the total number of reads in the library (possibility of a tag located on a base-pair per million reads). The Pearson product-moment correlation coefficient (r) of tag densities at genome-wide DHS between two libraries was calculated to indicate the correlation between different scDNase-seq libraries. For single-cell libraries, the reads out of the defined DHS regions were filtered and the number of reads in each 1,000-bp bin was counted to generate the single-cell heat map (Fig. 1b ). Any DHS region in a single cell with a reads located in was treated as open access thus a DHS in this single cell. For the pooled five single cells, any DHS region with at least two reads located in was treated as the DHS in the pooled five single cells.
The FDR of the DHS detected in single cells: in an NIH3T3 single-cell scDNase-seq library, the total number of observed DHSs and false positive (type I error) DHSs were denoted by N DHS and N FP , respectively. On the other hand, any reads that located out of the DHSs detected in ENCODE data must have been caused by noise generated during library preparation. The noise level (σ) should be the total number of reads that located out of the DHS in ENCODE data dividing by total length of the regions that are not DHS. The number of false positive DHSs Letter reSeArCH should be the genome-wide noise level (σ ) multiplying by the total length of the DHS. Thus, the FDR should be the number of false positive DHSs dividing by all the detected DHSs in single cell:
DHS
On the basis of this formula, we calculated the FDR for each NIH3T3 and ESC single-cell scDNase-seq library ( Supplementary Tables 2 and 7) . Differentially expressed genes and tissue-specific genes: the reads from RNAseq libraries were mapped to the mouse genome (mm9) or human genome (hg18) using Bowtie2 (ref. 32) . The gene expression level was measured by reads per kilobase per million mapped reads (RPKM) and number of reads in each gene. The cell-specific genes between ESC and NIH-3T3 were identified using EdgeR (FDR < 0.05; fold change > 1.5 or greater than two-thirds) 34 .
We used the tissue specificity index τ (ref. 35) to measure the tissue specificity of each gene, which is defined as the heterogeneity of its expression level across all the tissues. Assuming there are n tissues, the expression level of a gene in the jth tissue is E(j) and the highest expression level of the gene across all tissues is E max . Thus τ is calculated by
The values of τ range from 0 to 1, with higher values indicating higher variation of expression across tissues and thus higher tissue specificity, whereas lower values indicate lower variation of expression across tissues. The genes with the lowest τ could be considered as housekeeping genes. In this study, we calculated τ on the basis of gene atlas data from bioGPS. The 2,000 genes with the highest τ and the 2,000 genes with the lowest τ were treated as the tissue-specific genes and housekeeping genes, respectively.
The histone modification ChIP-seq data and peak calling: since the peaks of some histone marks such as H3K36me3 and H3K27me3 are very broad, we identified the tag-enriched peaks using SICER 36 , which takes advantage of the enrichment information from neighbouring bins to identify spatial clusters of signals that are unlikely to appear by chance. We set the window size to 200 bp and FDR = 0.01 for each histone modification ChIP-seq library, while we set the gap to 200 bp for H3K4me3, H3K9ac; 400 bp for H2A.Z; and 600 bp for the H3K4me1, H3K9me2, H3K27ac and H3K27me3. We calculated the tag densities of each active histone modification peak and identified whether the peak was a DHS in each single cell to find whether the enrichment of an active histone mark was correlated with the number of cells with DHS at the same locus. We calculated the tag densities of each single-cell scDNase-seq library at each DHS and examined whether a DHS co-occurred with these active histone modifications to find whether the chromatin accessibility in each single cell was correlated with the number of histone modifications in the same locus. Two peaks from different libraries were considered a co-occurrence if the overlapped region accounted for >10% of the length of a peak.
Reads around promoters and subpeaks of super-enhancers: the RefSeq genes (mm9 and hg18) were downloaded from the UCSC Genome Browser database. The regions ±1 kb around the TSS were treated as promoters in this study. The number of scDNase-seq reads located in a promoter was used to measure the chromatin accessibility of the promoter. We searched the super-enhancer in NIH3T3 via ROSE 15 on the basis of H3K27ac ChIP-seq and scDNase-seq data, respectively. We obtained a total of 275 high-confidence super-enhancers in NIH3T3 by identifying super-enhancers shown both in H3K27ac and in DNase-seq data. In addition, the 231 super-enhancers in ESCs reported in ref. 15 were used in this study. Subpeaks in super-enhancers were identified by MACS 33 and average read densities around these subpeaks of super-enhancers were calculated.
Single-cell-specific DHSs and gene set enrichment analysis: the number of reads located each DHS detected in ENCODE data in each NIH3T3 cell and ESC was counted. To examine whether the chromatin accessibility between NIH3T3 cells and ESCs was significantly different, a Wilcoxon signed-rank test was performed on the number of reads in the 5 NIH3T3 cells and 14 ESCs at each DHS. A DHS was active (indicated by 1) in a single cell if there was one or more than one reads located in the DHS region in the cell, while the alternative was not active (indicated by 0). Fisher's exact test on each locus was performed on the number of cells with active DHSs and the number of cells without active DHSs between the 5 NIH3T3 cells and 14 ESCs. The DHSs with P < 0.05 both by Wilcoxon test and by Fisher's test were treated as cell-type specific. Finally, we identified 1,735 single-cell NIH3T3-specific DHSs and 2,180 single-cell ESC-specific DHSs. We used gene set enrichment analysis 37 to determine whether the genes in the vicinity of the single-cell-specific DHSs showed statistically significant differences between NIH3T3 cells and ESCs on the basis of the gene expression data.
Gene ontology of single-cell NIH3T3-specific and ESC-specific DHSs: to predict the function of single-cell NIH3T3-specific or ESC-specific DHSs, we performed gene ontology analysis using GREAT 38 with the 1,735 NIH3T3-specific and 2,180 ESC-specific DHSs. It is clear that the single-cell ESC-specific DHSs are enriched with stem cell development and differentiation genes, and the single-cell NIH3T3-specific DHSs are enriched with genes with different functions (Extended Data Fig. 6g, h) . These results indicate that the ESC-specific and NIH3T3-specific DHSs identified in the single-cell scDNase-seq libraries predict important enhancers critical for tissue-specific gene expression.
Identifying tumour-specific mutation: we generated scDNase-seq libraries using tumour or their neighbouring cells recovered from FFPE tissue section slides. The sequence reads were mapped by Bowtie2 (ref. 32) . to the human reference genome (hg18). The paired reads with distance < 500 bp were kept if paired-end sequencing was performed. Then reads with MAPQ < 20 and possible duplication were removed by SAMtools 39 . Variation calling on each normal-tumour pair was conducted using SAMtools mpileup, with diploid model, MAPQ ≥ 20 and base alignment quality (BAQ) ≥ 30. The variations that only normal and tumour show different genotypes were kept. Then the low-quality variations were filtered (query quality (QUAL) < 20, mapping quality (MQ) < 20, phred probability of all samples being the same (FQ) < 0, variant distance bias (VDB < 0.01 and minor allele < 3). We obtained 31 variation candidates in FTC 440 ( Supplementary Table 13 ), many of them located on the predicted transcription-factor binding motifs.
Tumour-and normal-cell-specific DHS: the genome-wide DHSs were obtained by peak calling of the normal cell and tumour cell scDNase-seq libraries, respectively. The DHSs in normal cells and tumour cells were pooled, and reads in each library among the pooled DHSs were counted. The normal-and tumourcell-specific DHSs were identified using EdgeR. 
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